We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Adagio Medical Holdings Inc | NASDAQ:ADGM | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.02 | -1.89% | 1.04 | 1.00 | 1.10 | 1.1575 | 1.00 | 1.1575 | 13,282 | 23:56:58 |
From Sep 2024 to Mar 2025
Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the “Company”), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced its sponsorship and participation in the 19th Annual International Symposium on Ventricular Arrhythmias, to be held at the New York Marriott at the Brooklyn Bridge on October 11-12, 2024.
In addition to participating in the commercial exhibition, Adagio’s proprietary Ultra-Low Temperature Cryoablation (ULTC) technology will be featured within the scientific program of the Symposium.
Presentation Details:
Date: October 11, 2024 Time: 4:40 p.m. ET Topic: Cryocure-VT: One-year Results and Next Steps (FULCRUM-VT) Presenter: Dr. Atul Verma, Director, Division of Cardiology at McGill University Health Centre and FULCRUM-VT Co-Principal Investigator
Date: October 12, 2024 Time: 12:35 p.m. ET Topic: PVC Ablation using Ultra-low Cryoablation (Recorded Case) Presenter: Professor Dr. Roland Tilz, Director of the Department of Rhythmology at the University Clinic Schleswig-Holstein
“The annual VT Symposium is a seminal scientific and educational event for everyone involved and interested in the treatment of ventricular arrhythmias,” said Olav Bergheim, President and CEO of Adagio. “We are proud to be a continuing supporter and look forward to discussing our technology and clinical program with the top experts in the field.”
About Adagio Medical
Adagio Medical is an early commercial stage medical device company located in Laguna Hills, California focusing on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241007783534/en/
Media Contact Ilya Grigorov Vice President, Global Marketing and Product Management of Adagio Medical, Inc. igrigorov@adagiomedical.com
Investor Contact IR@adagiomedical.com
1 Year Adagio Medical Chart |
1 Month Adagio Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
